281
Participants
Start Date
February 1, 2025
Primary Completion Date
January 15, 2026
Study Completion Date
February 15, 2026
BDP/FF/G (Beclomethasone diprprionate, formoterol fumarate, glycopyrronium bromide) 172/5/9 μg
As this is a non-interventional study, it is accordance with routing clinical practice. The assignment of patients to Trimbow 172/5/9 mcg should be made independently from the study.
AIPSMCPP Dr. Elina Smilkova, Blagoevgrad
Medical Center Viva Phenix, Dobrich
Medical Center Hipocrat, Gabrovo
ASIMPIDPP Dr. Veselin Kalfov, Haskovo
Medical Center Denitza, Montana
IPASMC Dr. Kostadinka Sotirova, Pazardzhik
Group practice for specialized medical care - Asthma Center Pleven, Pleven
AIPSACA Dr. Talyat Cholak, Razgrad
AIPSMC Dr. Svetlan Mihaylov, Stara Zagora
Medical Center Third Policlinic, Stara Zagora
MHAT Svoge, Svoge
AIPSMCPP Dr. Nikolay Lichev V. Tarnovo, Veliko Tarnovo
Medical Center St. Ivan Rilski, Vidin
AIPSMCPP Dr. Bilyana Ivanova, Vratsa
Chiesi Bulgaria
INDUSTRY